IMF Videos Search Content For Healthcare Provider (392) Healthcare Professional (389) Care Partner (333) Patient (328) Series - Any - About the IMF (2) ASCO/EHA (163) ASH (230) Ask Dr. Durie (238) Black Swan Research Initiative (7) Community Workshops (33) Emerging Therapies (20) Facebook Live (21) Health Equity (16) IMF History (4) IMWG (13) Inspirational (16) Living Well with Myeloma (34) Myeloma in a Minute (19) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (27) Q&A (19) Recent News and Developments (4) Treatments (4) Trending Searches in Myeloma (1) Topics Clinical Trials (365) Financial Considerations (18) Frontline Therapy (163) Health Equity (40) Inspirational Stories (24) Insurance (5) Lab & Imaging Tests (78) Lifestyle (53) Mental & Emotional Health (31) Myeloma 101 (75) Myeloma in the News (6) Public Policy & Advocacy (20) Q&A's (40) Recorded Seminars & Workshops (47) Recorded Webinars (27) Relapse/Refractory Myeloma (283) Research Updates (345) Symptom Management (158) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (211) High-Risk Myeloma (153) High-risk Smoldering Myeloma (90) Late Relapse (4–6 Lines of Therapy) (271) MGUS (78) Newly Diagnosed (Pre-Treatment or First Treatment) (246) Smoldering Myeloma (116) Types of Therapy Immunomodulatory drugs (IMiDs) (183) Immunotherapies (CAR T; BiTE, etc.) (250) Monoclonal antibodies (157) Proteasome inhibitors (140) Stem cell transplant (141) Steroids (92) Supportive Care (192) Year Published 2026 (35) 2025 (109) 2024 (102) 2023 (115) 2022 (111) 2021 (126) 2020 (81) 2019 (76) 2018 (55) 2017 (37) 2016 (26) 2015 (36) Trusted Voices Dr. Brian GM Durie (214) Dr. Joseph Mikhael (107) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (28) Dr. María-Victoria Mateos (13) Dr. Saad Usmani (11) Dr. Shaji Kumar (6) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Sagar Lonial (5) Dr. Rafat Abonour (4) Dr. Sigurður Kristinsson (4) Dr. Urvi A. Shah (4) Dr. Tom Martin (3) Dr. Philippe Moreau (1) Dr. S. Vincent Rajkumar (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance MagnetisMM-3: Long-Term Efficacy & Safety of Less Frequent Elranatamab Dosing in Relapsed Refractory Multiple Myeloma February 25, 2025 ASH Daratumumab vs Active Monitoring in High-Risk Smoldering Multiple Myeloma: Aquila Study Results February 24, 2025 ASH What Is the Prognosis for Multiple Myeloma? | Myeloma in a Minute or Less February 20, 2025 Myeloma in a Minute MagnetisMM-9: Efficacy and Safety of Step-up Priming Doses and Longer Dosing Intervals of Elranatamab in Patients with Relapsed or Refractory Multiple Myeloma February 19, 2025 ASH Lisaftoclax Combined with Novel Therapies in Relapsed/Refractory Multiple Myeloma and Amyloidosis February 14, 2025 ASH Belantamab Mafodotin with VRd in ASCT-Ineligible Newly Diagnosed Multiple Myeloma: DREAMM-9 Study Findings February 13, 2025 ASH Q&A | Hope for High-Risk Multiple Myeloma: Latest Treatments & Life Expectancy Insights February 13, 2025 Q&A Patient-Centric Myeloma Research at ASH 2024: Quality of Life, Exercise, Nutrition & More February 11, 2025 ASH Myeloma Research: Late Relapse, CAR T-Cell Therapy & Bispecific Antibodies at ASH 2024 February 11, 2025 ASH Belantamab & CAR T-Cell Therapy: Key ASH 2024 Updates on Early Myeloma Relapse February 6, 2025 ASH Frontline Therapy Advances for Multiple Myeloma Patients | ASH 2024 Insights for Patients January 30, 2025 ASH MRD Progression in Newly Diagnosed MM: What Happens After Quad Therapy and Stem Cell Transplant? January 28, 2025 ASH Load More
